Early pregnancy care

Published on 09/03/2015 by admin

Filed under Obstetrics & Gynecology

Last modified 09/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3175 times

Early pregnancy care

Ian Symonds

Bleeding in early pregnancy

Vaginal bleeding occurs in up to 25% of pregnancies prior to 20 weeks. It is a major cause of anxiety for all women, especially those who have experienced previous pregnancy loss, and may be the presenting symptom of life-threatening conditions such as ectopic pregnancy. Bleeding should always be considered as abnormal in pregnancy and investigated appropriately.

A small amount of bleeding may occur as the blastocyst implants in the endometrium 5–7 days after fertilization (implantation bleed). If this occurs at the time of expected menstruation it may be confused with a period and so effect calculations of gestational age based on the last menstrual period.

The common causes for bleeding in early pregnancy are miscarriage, ectopic pregnancy and benign lesions in the lower genital tract. Less commonly it may be the presenting symptom of hydatiform mole or cervical malignancy.

Miscarriage

The recommended medical term for pregnancy loss less than 24 weeks gestation is ‘miscarriage’. In some countries, such as the US, this term is used to describe pregnancy loss before fetal viability or a fetal weight of less than 500 g. In some states in Australia the term is used for any pregnancy loss under 20 weeks gestation. Most miscarriages occur in the second or third month and occur in 10–20% of clinical pregnancies. It has been suggested that a much higher proportion of pregnancies miscarry at an early stage if the diagnosis is based on the presence of a significant plasma level of beta-subunit human chorionic gonadotrophin (hCG).

The aetiology of miscarriage

In many cases no definite cause can be found for miscarriage. It is important to identify this group as the prognosis for future pregnancy is generally better than average.

Genetic abnormalities

Chromosomal abnormalities are a common cause of early miscarriage and may result in failure of development of the embryo with formation of a gestation sac without the development of an embryo or with later expulsion of an abnormal fetus. In any form of miscarriage, up to 55% of products of conception will have an abnormal karyotype. The most common chromosomal defects are autosomal trisomies, which account for half the abnormalities, while polyploidy and monosomy X account for a further 20% each. Although chromosome abnormalities are common in sporadic miscarriage, parental chromosomal abnormalities are present in only 3–5% of partners presenting with recurrent pregnancy loss. These are most commonly balanced reciprocal or Robertsonian translocations or mosaicisms.

Abnormalities of the uterus

Congenital abnormalities of the uterine cavity, such as a bicornuate uterus or subseptate uterus, may result in miscarriage (Fig. 18.1). Uterine anomalies can be demonstrated in 15–30% of women experiencing recurrent miscarriages. The impact of the abnormality depends on the nature of the anomaly. The fetal survival rate is 86% where the uterus is septate and worst where the uterus is unicornuate. It must also be remembered that over 20% of all women with congenital uterine anomalies also have renal tract anomalies. Following damage to the endometrium and inner uterine walls, the surfaces may become adherent, thus partly obliterating the uterine cavity (Asherman’s syndrome). The presence of these synechiae may lead to recurrent miscarriage.

Clinical types of miscarriage

Threatened miscarriage

The first sign of an impending miscarriage is the development of vaginal bleeding in early pregnancy (Fig. 18.2). The uterus is found to be enlarged and the cervical os is closed. Lower abdominal pain is either minimal or absent. Most women presenting with a threatened miscarriage will continue with the pregnancy irrespective of the method of management.

Inevitable/incomplete miscarriage

The patient develops abdominal pain usually associated with increasing vaginal bleeding. The cervix opens, and eventually products of conception are passed into the vagina. However, if some of the products of conception are retained, then the miscarriage remains incomplete (Fig. 18.3).

Miscarriage with infection (sepsis)

During the process of miscarriage – or after therapeutic termination of a pregnancy – infection may be introduced into the uterine cavity. The clinical findings of septic miscarriage are similar to those of incomplete miscarriage with the addition of uterine and adnexal tenderness. The vaginal loss may become purulent and the patient pyrexial. In cases of severe overwhelming sepsis, endotoxic shock may develop with profound and sometimes fatal hypotension. Other manifestations include renal failure, disseminated intravascular coagulopathy and multiple petechial haemorrhages. Organisms which commonly invade the uterine cavity are Escherichia coli, Streptococcus faecalis, Staphylococcus albus and S. aureus, Klebsiella, Clostridium welchii and C. perfringens.

Missed miscarriage (empty gestation sac, embryonic loss, early and late fetal loss)

In empty gestation sac (anembryonic pregnancy or blighted ovum) a gestational sac of ≥25 mm is seen on ultrasound (Fig. 18.4), but there is no evidence of an embryonic pole or yolk sac or change in size of the sac on rescan 7 days later. Embryonic loss is diagnosed where there is an embryo ≥7 mm in size without cardiac activity or where there is no change in the size of the embryo after 7 days on scan. Early fetal demise occurs when a pregnancy is identified within the uterus on ultrasound consistent with 8–12 weeks size, but no fetal heartbeat is seen. These may be associated with some bleeding and abdominal pain or be asymptomatic and diagnosed on ultrasound scan. The pattern of clinical loss may indicate the underlying aetiology, for example, antiphospholipid syndrome tends to present with recurrent fetal loss.

Management

Examination of the patient should include gentle vaginal and speculum examination to ascertain cervical dilatation. If there is pyrexia, a high vaginal swab should be taken for bacteriological culture.

Some women may prefer not to be examined because of apprehension that the examination may promote miscarriage, and their wishes should be respected. Management in dedicated early pregnancy assessment units (EPAU) reduces the need for hospital admission and length of stay. An ultrasound scan is valuable in deciding if the fetus is alive and normal. One effect of the routine use of scans in early pregnancy is that the diagnosis of miscarriage may be established before there is any indication that the pregnancy is abnormal. It is sometimes preferable to repeat the scan a week later than proceed to immediate medical or surgical uterine evacuation, to enable the mother to come to terms with the diagnosis.

Miscarriage may be complicated by haemorrhage and severe pain, and may necessitate blood transfusion and relief of pain with opiates. If there is evidence of infection, antibiotic therapy should be started immediately and adjusted subsequently if the organism identified in culture is not sensitive to the prescribed antibiotic.

Non-sensitized Rhesus (Rh) negative women should receive anti-D immunoglobulin for miscarriages over 12 weeks of gestation (including threatened) and all miscarriages where the uterus is evacuated (whether medically or surgically).

Anti-D immunoglobulin should only be given for threatened miscarriages under 12 weeks gestation when bleeding is heavy or associated with pain. It is not required for cases of complete miscarriage under 12 weeks of gestation when there has been no formal intervention to evacuate the uterus.

Surgical management

Buy Membership for Obstetrics & Gynecology Category to continue reading. Learn more here